Robert V. Baumgartner - Aug 8, 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed.
Stock symbol: TECH
Transactions as of: Aug 8, 2024
Transactions value $: -$786,464
Form type: 4
Date filed: 8/12/2024, 04:08 PM
Previous filing: Oct 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TECH	Common Stock	Options Exercise	$367K	+16K	+36.87%	$22.95	59.4K	Aug 8, 2024	Direct
transaction	TECH	Common Stock	Sale	-$1.15M	-16K	-26.94%	$72.10	43.4K	Aug 8, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TECH	Stock Options (Right to Buy)	Options Exercise	$0	-16K	-100%	$0.00^*	0	Aug 8, 2024	Common Stock	16K	$22.95	Direct
holding	TECH	Stock Options (Right to Buy)						17K	Aug 8, 2024	Common Stock	17K	$21.84	Direct
holding	TECH	Stock Options (Right to Buy)						15.9K	Aug 8, 2024	Common Stock	15.9K	$25.30	Direct
holding	TECH	Stock Options (Right to Buy)						12.5K	Aug 8, 2024	Common Stock	12.5K	$31.26	Direct
holding	TECH	Stock Options (Right to Buy)						7.59K	Aug 8, 2024	Common Stock	7.59K	$44.96	Direct
holding	TECH	Stock Options (Right to Buy)						8.04K	Aug 8, 2024	Common Stock	8.04K	$50.41	Direct
holding	TECH	Stock Options (Right to Buy)						6.03K	Aug 8, 2024	Common Stock	6.03K	$63.92	Direct
holding	TECH	Stock Options (Right to Buy)						2.53K	Aug 8, 2024	Common Stock	2.53K	$128.81	Direct
holding	TECH	Stock Options (Right to Buy)						3.46K	Aug 8, 2024	Common Stock	3.46K	$73.94	Direct
holding	TECH	Stock Options (Right to Buy)						3.94K	Aug 8, 2024	Common Stock	3.94K	$61.51	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.33 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.33 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders.